Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cory D Emal

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 9, 2010
Novel bis-arylsulfonamides and aryl sulfonimides as inactivators of plasminogen activator inhibitor-1 (PAI-1)Nadine C El-Ayache, Shih-Hon Li, Mark Warnock, et al.
Phlebology|January 22, 2026
PAI-1 Inhibition in experimental venous thrombosisMaxim E Shaydakov, Cory D Emal, Joshua P Rainey, et al.
The Journal of Biological Chemistry|December 4, 2019
High-affinity binding of plasminogen-activator inhibitor 1 complexes to LDL receptor-related protein 1 requires lysines 80, 88, and 207Mary Migliorini, Shih-Hon Li, Anqi Zhou, et al.
Translational Stroke Research|February 5, 2022
Compartmentalized Actions of the Plasminogen Activator Inhibitors, PAI-1 and Nsp, in Ischemic StrokeDaniel Torrente, Enming Joseph Su, Linda Fredriksson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013
Mechanistic characterization and crystal structure of a small molecule inactivator bound to plasminogen activator inhibitor-1Shih-Hon Li, Ashley A Reinke, Karen L Sanders, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 10, 2020
Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic SyndromeHekmat B Khoukaz, Yan Ji, Drew J Braet, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2002
Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfonesBhaskar R Shenai, Belinda J Lee, Alejandro Alvarez-Hernandez, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Structure activity studies of a novel cytotoxic benzodiazepineAnthony Boitano, Cory D Emal, Francesco Leonetti, et al.
The Journal of Biological Chemistry|January 12, 2010
Characterization of a novel class of polyphenolic inhibitors of plasminogen activator inhibitor-1Jacqueline M Cale, Shih-Hon Li, Mark Warnock, et al.
The Journal of Biological Chemistry|December 5, 2018
Dual-reporter high-throughput screen for small-molecule <i>in vivo</i> inhibitors of plasminogen activator inhibitor type-1 yields a clinical lead candidateAshley A Reinke, Shih-Hon Li, Mark Warnock, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|January 9, 2010
Novel bis-arylsulfonamides and aryl sulfonimides as inactivators of plasminogen activator inhibitor-1 (PAI-1)Nadine C El-Ayache, Shih-Hon Li, Mark Warnock, et al.
Phlebology|January 22, 2026
PAI-1 Inhibition in experimental venous thrombosisMaxim E Shaydakov, Cory D Emal, Joshua P Rainey, et al.
The Journal of Biological Chemistry|December 4, 2019
High-affinity binding of plasminogen-activator inhibitor 1 complexes to LDL receptor-related protein 1 requires lysines 80, 88, and 207Mary Migliorini, Shih-Hon Li, Anqi Zhou, et al.
Translational Stroke Research|February 5, 2022
Compartmentalized Actions of the Plasminogen Activator Inhibitors, PAI-1 and Nsp, in Ischemic StrokeDaniel Torrente, Enming Joseph Su, Linda Fredriksson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013
Mechanistic characterization and crystal structure of a small molecule inactivator bound to plasminogen activator inhibitor-1Shih-Hon Li, Ashley A Reinke, Karen L Sanders, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 10, 2020
Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic SyndromeHekmat B Khoukaz, Yan Ji, Drew J Braet, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2002
Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfonesBhaskar R Shenai, Belinda J Lee, Alejandro Alvarez-Hernandez, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Structure activity studies of a novel cytotoxic benzodiazepineAnthony Boitano, Cory D Emal, Francesco Leonetti, et al.
The Journal of Biological Chemistry|January 12, 2010
Characterization of a novel class of polyphenolic inhibitors of plasminogen activator inhibitor-1Jacqueline M Cale, Shih-Hon Li, Mark Warnock, et al.
The Journal of Biological Chemistry|December 5, 2018
Dual-reporter high-throughput screen for small-molecule <i>in vivo</i> inhibitors of plasminogen activator inhibitor type-1 yields a clinical lead candidateAshley A Reinke, Shih-Hon Li, Mark Warnock, et al.
Pageof 2